688617 惠泰医疗
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)7.57529.28230.43529.09320.219
总资产报酬率 ROA (%)6.47924.74624.24222.25216.891
投入资产回报率 ROIC (%)7.37528.58529.11827.32619.242

边际利润分析
销售毛利率 (%)72.42672.87772.31371.26671.204
营业利润率 (%)37.72936.55536.48436.38432.647
息税前利润/营业总收入 (%)38.38135.98335.50435.94232.273
净利润/营业总收入 (%)32.06531.26031.86031.64027.973

收益指标分析
经营活动净收益/利润总额(%)95.18197.39197.42989.58394.164
价值变动净收益/利润总额(%)4.0191.8611.7663.8795.338
营业外收支净额/利润总额(%)-0.043-0.883-1.035-0.679-0.470

偿债能力分析
流动比率 (X)5.2024.6243.9822.9863.781
速动比率 (X)3.8753.5522.9992.4282.961
资产负债率 (%)12.34214.28114.28723.74619.538
带息债务/全部投入资本 (%)0.8570.5511.5725.7414.105
股东权益/带息债务 (%)11,336.54017,698.7706,212.1551,622.8042,308.037
股东权益/负债合计 (%)701.248592.258590.892312.144405.440
利息保障倍数 (X)57.429-142.856-58.513-182.126-145.934

营运能力分析
应收账款周转天数 (天)8.68911.25110.8669.66112.014
存货周转天数 (天)225.375228.909228.878252.775309.035